Reliable identification of different melanoma cell lines is important for many aspects of melanoma research. Common markers used to identify melanoma cell lines include: S100; HMB-45; and Melan-A. We explore the expression of these three markers in four different melanoma cell lines: WM35; WM793; SK-MEL-28; and MM127. The expression of these markers is examined at both the mRNA and protein level. Our results show that the metastatic cell line, MM127, cannot be detected using any of the commonly used melanoma-associated markers. This implies that it would be very difficult to identify this particular cell line in a heterogeneous sample, and as a result this cell line should be used with care.
Introduction
Melanoma is an aggressive form of skin cancer that has the highest incidence rate in Australia 1 . Since many aspects of melanoma research rely on the use of various types of melanoma cell lines 2,3 , the reliable identification of different melanoma cell lines is very important.
A range of melanoma-associated markers are used to identify different types of melanoma cell lines 4 . The three most frequently used markers are: S100; HMB-45 and Melan-A 5, 6 . A common feature of many experimental investigations is that some melanoma cell lines are unable to be detected using certain markers 7 . To address this limitation, many studies use two different markers to ensure reliable identification 8 .
MM127 is a metastatic melanoma cell line of human origin, isolated in 1970 9 . Since then, MM127 melanoma cells have been used in many published investigations. For example, MM127 cells have been used in ultraviolet radiation studies 10 , gene-based studies 11 , drug-response studies 12 and in other melanoma-associated research.
Some of our previous work involves investigating how the balance of the rate of cell migration and the rate of cell proliferation affects the collective spreading of a population of MM127 melanoma cells 13 . In this previous study we describe results from an in vitro monoculture circular barrier assay 14, 15 , and we use a discrete random walk mathematical model to quantify the rates of cell migration and cell proliferation 3 in the experiment. Because this previous study involves a monoculture assay with just one cell type present, we did not attempt to identify the MM127 cells using any melanoma-associated markers. One way to extend this previous work would be to perform more complicated co-culture experiments. Such an extension would require the identification of the MM127 melanoma cells amongst the total population of cells in the assay. To meet this aim we first need to establish whether we can reliably identify MM127 melanoma cells using standard melanoma-associated markers. The focus of the present study is to explore whether MM127 cells can be reliably identified using standard approaches.
This work is organised in the following way. In the Results section we describe the outcomes of three different experimental techniques for identifying different melanoma cell lines using S100, HMB-45, and Melan-A. These techniques include immunofluorescence, Western blotting, and quantitative reverse transcriptionpolymerase chain reaction (qRT-PCR) assays. These techniques are applied to four different melanoma cell lines, and the results for the metastatic melanoma cell line, MM127, are not as expected. We find that this cell line is not identifiable using any of the three markers.
Results

Short tandem repeat profiling
All melanoma cell lines: WM35; WM793; SK-MEL-28 and MM127, are validated using short tandem repeat (STR) profiling (Cell Bank, Australia. January 2015). The STR profiling results confirm that all these melanoma cell lines are identical to the reference samples held at Cell Bank (Supplementary information). Therefore, all melanoma cell lines in this study are identical to the reference samples held at Cell Bank.
The alleles obtained from STR profiling are analysed using the DMSZ database (http://www.dsmz.de/fp/cgi-bin/str.html) to give the closest match to each cell line we consider. The results from this analysis confirm that WM35, WM793 and SK-MEL-28 are as expected (Supplementary information). Conversely, the results for MM127 are not as expected since there is no match identified using the MM127 alleles [ Fig.   1 (a)]. This preliminary result suggests that further investigation is warranted.
Immunofluorescence
Immunofluorescence is used on fixed cell preparations for S100, HMB-45 and Melan-A. The cell nuclei, f-actin and three standard melanoma-associated markers are highlighted [ Fig. 1(b) ]. S100 is localised to the nucleus and cytoplasm, and is observed in WM35, WM793 and SK-MEL-28 cells. HMB-45 is detected in the cytoplasm of WM35, WM793 and SK-MEL-28 cells [ Fig. 1(b) ]. Melan-A staining is present in both the WM35 and SK-MEL-28 cells, whereas it is absent from WM793 cells. Interestingly, MM127 is the only melanoma cell line that is negative for all three melanoma-associated markers in the immunofluorescence investigations. To confirm the immunofluorescence results, Western blotting analysis is performed.
Western blotting
The expression of S100 (10kDa), HMB-45 (27 and 100kDa), and Melan-A (18kDa) proteins in the WM35, WM793, SK-MEL-28, MM127 and HaCaT cell lines are analysed using Western blots. The expression of these markers is also examined in primary cells, including keratinocytes and fibroblasts, showing that both keratinocytes and fibroblasts are negative for S100, HMB-45 and Melan-A [ Fig. 1(c) ].
The expression of these markers is also examined in primary melanocytes, showing that they are positive for S100, HMB-45 and Melan-A [ Fig. 1(c) ].
In the SK-MEL-28 and WM35 cell lines, HMB-45 is detected as two bands, which is consistent with previous results 16 The qRT-PCR results indicate that the expression of S100 (S100B), Melan-A (MLANA) and HMB-45 (PMEL) in MM127 is very similar to the negative control [ Fig.   1(d) ]. The gene level for S100 in the HaCaT and MM127 cell lines is below the detectable limit (BDL). Overall, these qRT-PCR results are consistent with the Western blotting and immunofluorescence analysis, and confirm that these three standard melanoma-associated markers are not detected in the MM127 cell line. 7 To further verify the qRT-PCR results, the gene expression of two other commonlyused melanoma markers: microphthalmia-associated transcription factor (MITF); and tyrosinase (TYR) 18 are also examined. Again, the expression of MITF and TYR in the MM127 cells are very similar to the negative control (Supplementary information).
Discussion
Our group, and several other research groups, have previously worked with the metastatic melanoma cell line, MM127 13, [19] [20] [21] . Our previous work involves performing and analysing two-dimensional barrier assays with MM127 cells in monoculture 13, 21 . Since these previous studies involve a monoculture experiment, there was no need to identify the cells within the experiment since all cells are known to be MM127 cells. If these monoculture experiments are to be extended to coculture conditions, with multiple cell types present, we would be interested in identifying the MM127 cells within the total heterogeneous population. The results of the present study indicate that making this kind of distinction using standard melanoma-associated markers would be very difficult because MM127 cells cannot be identified using S100, Melan-A, HMB-45, MITF or tyrosinase.
Immunofluorescence on WM35, WM793 and SK-MEL-28 show positive expression of all the melanoma-associated markers considered, while the negative control,
HaCaT cells, and the metastatic melanoma cell line MM127 did not express any of the markers we consider. All antibodies are used at an optimal dilution which we determined using a series of sensitivity assays specifically optimised for each marker prior to proceeding with the experiments. The Western blot analysis also shows the presence of all markers in WM35 and SK-MEL-28, and S100 in WM793. In contrast, all melanoma-associated markers considered are absent in the negative control and the MM127 cell line.
We find that the WM793 cell line does not express all the melanoma markers considered. One possible explanation for a variation between the immunofluorescence and Western blot analysis for WM793 cells is that a longer 9 period of time might be needed to expose the blot. However, using a longer period of time might cause an over expression of proteins in the other lanes. We are not concerned by this variation since WM793 cells reliably express S100, and so can be identified using this marker. On the contrary, MM127 cells cannot be identified using any of the commonly used markers we consider.
Collectively, our findings indicate that the standard melanoma-associated markers we consider are not detected in the MM127 cell line. Although the MM127 cell line has been used in several previous studies 13, [19] [20] [21] , we find that this cell line cannot be detected using standard melanoma-associated markers. Therefore, we suggest that other metastatic melanoma cell lines that express standard markers, such as the SK-MEL-28 cell line, ought to be used in preference to the MM127 cell line.
Since the MM127 cells we use in this study and the MM127 cells available from Cell
Bank Australia are sourced from the same institution, it is not surprising that the cell validation results confirm that the cells we use are 100% identical to those available from Cell Bank (Supplementary information). However, since the MM127 cell line was first discussed in 1979 9 , it is possible that the MM127 cells currently available from Cell Bank are somehow different to the cells originally reported in 1979. Given that MM127 cells are primarily in use at one research institution, it is impossible to for us to repeat our investigations using samples of MM127 cells sourced from multiple institutions.
Certain recent investigations have shown that MM127 cells are positive for the NRAS mutation which is consistent with the idea that these cells are melanoma [22] [23] .
Regardless of their NRAS status, our observation that MM127 cells cannot be detected using standard melanoma-associated markers is an important finding. Epidermal cells, at a density of 8x10 4 cells/cm 2 , are seeded and incubated at 37°C in 5% CO 2 and 95% air. If the melanocyte culture is contaminated with fibroblasts it is treated with 100μg/ml of Geneticin® (Life Technologies) for 2-3 days.
Fibroblast culture: The dermis, obtained after keratinocyte isolation, is finely minced and placed in a 0.05% collagenase A type I (Life Technologies) solution prepared in DMEM at 37°C, in 5% CO 2 and 95% air for 24 hours. The dermal cell solution is centrifuged at 212g for 10 minutes and the cells are seeded into T75cm 2 flasks (Nunc®) in DMEM with 10% FCS, 2mM L-glutamine, 50U/ml of penicillin and 50μg/ml of streptomycin at 37° C in 5% CO 2 and 95% air. 1 3 Immunofluorescence Cells are grown on glass coverslips and fixed with 4% paraformaldehyde (Electron Microscopy Sciences, Australia) for 30 minutes at room temperature. Cells are permeabilised with 0.1% Triton-X in PBS for 10 minutes, washed with 0.5% w/v bovine serum albumin (BSA) (Life Technologies) in PBS and the non-specific binding sites are blocked using 0.5% BSA for 30 minutes. This is followed by the addition of primary antibody (S100-1:2500, HMB-45-1:100 and Melan-A-1:200) (Dako, Australia) on cells for an hour, and the secondary antibody (Alexa Fluor® 480-1:400 and Alexa Fluor 555®-1:400) (Life Technologies) for an hour. Before proceeding with our experiments, we perform a series of experiments to determine the optimal dilution for each antibody. The optimal dilution was determined by starting with the manufacturer's recommended dilution and then increasing the dilution to find an optimum result. Cells are washed three times with 0.5% BSA, the nucleus is stained Results below the detectable limit are given as BDL.
